University of Wollongong

Research Online
Illawarra Health and Medical Research Institute

Faculty of Science, Medicine and Health

2020

Study protocol the Continuing Care Project: A randomised
controlled trial of a continuing care telephone intervention
following residential substance dependence treatment
Peter James Kelly
University of Wollongong, pkelly@uow.edu.au

Frank P. Deane
University of Wollongong, fdeane@uow.edu.au

Gerard Byrne
Tayla Degan
University of Wollongong, tjd589@uowmail.edu.au

Briony Osborne
University of Wollongong

See next page for additional authors
Follow this and additional works at: https://ro.uow.edu.au/ihmri
Part of the Medicine and Health Sciences Commons

Recommended Citation
Kelly, Peter James; Deane, Frank P.; Byrne, Gerard; Degan, Tayla; Osborne, Briony; Townsend, Camilla;
McKay, James; Robinson, Laura; Oldmeadow, Christopher; Lawson, Kenny; Searles, Andrew; and Lunn,
Joanne, "Study protocol the Continuing Care Project: A randomised controlled trial of a continuing care
telephone intervention following residential substance dependence treatment" (2020). Illawarra Health
and Medical Research Institute. 1515.
https://ro.uow.edu.au/ihmri/1515

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Study protocol the Continuing Care Project: A randomised controlled trial of a
continuing care telephone intervention following residential substance
dependence treatment
Abstract
Background: A priority area in the field of substance dependence treatment is reducing the rates of
relapse. Previous research has demonstrated that telephone delivered continuing care interventions are
both clinically and cost effective when delivered as a component of outpatient treatment. This protocol
describes a NSW Health funded study that assesses the effectiveness of delivering a telephone delivered
continuing care intervention for people leaving residential substance treatment in Australia. Methods/
design: All participants will be attending residential alcohol and other drug treatment provided by The
Salvation Army or We Help Ourselves. The study will be conducted as a randomised controlled trial, where
participants will be randomised to one of three treatment arms. The treatment arms will be: (i) 12-session
continuing care telephone intervention; (ii) 4-session continuing care telephone intervention, or (iii)
continuing care plan only. Baseline assessment batteries and development of the participants' continuing
care plan will be completed prior to participants being randomised to a treatment condition. Research
staff blind to the treatment condition will complete follow-up assessments with participants at 3-months
and 6-months after they have been discharged from their residential service. Discussion: This study will
provide comprehensive data on the effect of delivering the continuing care intervention for people exiting
residential alcohol and other drug treatment. If shown to be effective, this intervention can be
disseminated to improve the rates of relapse among people leaving residential alcohol and other drug
treatment.
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Study protocol the Continuing Care Project:
a randomised controlled trial of a
continuing care telephone intervention
following residential substance
dependence treatment
Peter Kelly1,2* , Frank Deane1,2, Gerard Byrne3, Tayla Degan1,2, Briony Osborne1,2, Camilla Townsend1,2,
James McKay4, Laura Robinson1,2, Christopher Oldmeadow5, Kenny Lawson5, Andrew Searles5 and Joanne Lunn6

Abstract
Background: A priority area in the field of substance dependence treatment is reducing the rates of relapse.
Previous research has demonstrated that telephone delivered continuing care interventions are both clinically and
cost effective when delivered as a component of outpatient treatment. This protocol describes a NSW Health
funded study that assesses the effectiveness of delivering a telephone delivered continuing care intervention for
people leaving residential substance treatment in Australia.
Methods/design: All participants will be attending residential alcohol and other drug treatment provided by The
Salvation Army or We Help Ourselves. The study will be conducted as a randomised controlled trial, where
participants will be randomised to one of three treatment arms. The treatment arms will be: (i) 12-session
continuing care telephone intervention; (ii) 4-session continuing care telephone intervention, or (iii) continuing care
plan only. Baseline assessment batteries and development of the participants’ continuing care plan will be
completed prior to participants being randomised to a treatment condition. Research staff blind to the treatment
condition will complete follow-up assessments with participants at 3-months and 6-months after they have been
discharged from their residential service.
Discussion: This study will provide comprehensive data on the effect of delivering the continuing care intervention
for people exiting residential alcohol and other drug treatment. If shown to be effective, this intervention can be
disseminated to improve the rates of relapse among people leaving residential alcohol and other drug treatment.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12618001231235. Registered on 23rd July
2018. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375621&isReview=true
Keywords: Continuing care, Telephone, The salvation Army, We help ourselves, Substance use, Methamphetamine,
Alcohol, Mental health
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Background
Relapse rates are high for people attending alcohol and
other drug (AOD) treatment [1]. Studies indicate that between 40 to 70% of participants leaving residential services
report some use of alcohol or other drugs in the first six
months after leaving residential treatment [2, 3]. To improve treatment outcomes and reduce relapse rates, continuing care interventions are recommended [4–6].
‘Aftercare’ services provided by residential services are
typically focused on referral only (e.g., referral to services in
the person’s local area, referral to 12-step groups). It is
likely that adding a more ‘active’ continuing care component to treatment as usual will help to reduce relapse rates
and improve participants’ transition back into the community [4–6]. Several modalities for delivering active continuing care have been studied, these include cognitive
behavioural therapy, motivational interviewing, 12-step oriented and process groups. There are now a number of reviews [5, 6] and meta-analyses [4] that support the use of
continuing care to promote longer-term outcomes. Across
a variety of treatment settings (e.g., following detoxification,
outpatient treatment or residential programs) and using different forms of continuing care (e.g. face to face, attendance
at mutual support groups) the effects are significant (g =
0.27, p < .01, n = 13) [4]. Despite likely benefits of continuing care interventions, implementation can be hampered by
low uptake [7], lack of service resources [8], ease of access
(e.g., to transport) [6] and individual characteristics of the
person leaving treatment (e.g., beliefs and attitudes towards
after-care, level of motivation, readiness to change) [8, 9].
Telephone based continuing care is likely to be a wellsuited modality for overcoming several of these barriers.
McKay and colleagues have developed a standardised
Continuing care telephone intervention [10] that has
been successfully trialled in the United States to support
people who have completed intensive outpatient treatment [10]. In a randomised controlled trial, telephone
delivered continuing care (i.e., 12-sessions, the first session was completed face-to-face and then subsequent
sessions were completed over the telephone) was compared with other forms of more intensive continuing care.
These included face-to-face relapse prevention training
(1x individual session and 1 x group session per week)
and treatment as usual (2 × 12-step groups per week for
12-weeks). Results demonstrated that the telephone intervention was as effective as the more intensive approaches
to continuing care in increasing the percentage of days abstinent and reducing negative consequences of substance
use. Encouragingly, the participants completing the telephone condition demonstrated a higher percentage of
days abstinent than the standard condition.
Subsequent economic analysis of the telephone approach
has found that it is cost effective to deliver [6, 10–12]. The
protocol developed by McKay is listed on SAMHSA’s
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National Registry of Evidence Based Programs and Practices (NREPP). However, published research has not examined the effectiveness of this program to support people
leaving therapeutic communities, nor has it examined the
intervention within an Australian context.
Objectives

The Continuing Care Project will examine the continuing
care intervention developed by McKay and colleagues
(2005) for people exiting residential AOD treatment in
Australia. The proposed study addresses calls in the
broader academic literature to conduct well-controlled
studies in this field [4–6]. It is hypothesised that: (i) participants in the continuing care treatment arms will demonstrate significantly higher percentages of days abstinent
from alcohol and other drugs (excluding tobacco) at
follow-up compared to the control (continuing care plan
only) arm; (ii) that participants in the 12-session continuing
care arm will demonstrate higher percentages of days abstinent at follow-up compared to the 4-session arm. Study
results will also provide important information on the cost
effectiveness of including continuing care telephone interventions as part of routine rehabilitation services.

Methods
Setting

Participants will be attending residential AOD treatment
provided by The Australian Salvation Army and We Help
Ourselves (WHOS). All of the treatment sites were located in New South Wales, Australia. The Salvation Army
programs are: William Booth House (102 beds, including
82 for males and 20 for females) and the Dooralong
Transformation Centre (150 beds, including 110 for males
and 40 for females). The treatment program across both
sites is a minimum 3 months in length and is operated in
the form of a modified therapeutic community. Previous
research has described these programs and examined the
characteristics of people accessing these services [13–17].
The WHOS sites are: Gunyah (29 male beds) and New
Beginnings (19 female beds). WHOS is operated in the
form of a therapeutic community and participants may
stay for 3 to 4 months. Previous research has also described the WHOS program characteristics or participants
attending these programs [18, 19].
Design

A multi-centre prospective, randomised, open, blinded
endpoint (PROBE) design will be utilised to compare the
three study conditions. All three study arms will include
usual care (i.e. aftercare planning, referral to 12-step meetings) and the completion of a continuing care plan. The
study arms are as follows; (i) 12-session continuing care
telephone intervention over a 3-month period following
discharge from the treatment program; (ii) 4-session
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continuing care telephone intervention over a 1-month
period, following discharge from the treatment program,
or (iii) usual care plus a continuing care plan only. Assessments will be conducted at baseline, at 3-months post discharge from the treatment program, and at 6-months post
discharge. At each assessment time point the assessment
officers will be blind to the treatment condition. Fig. 1 describes the study flow.
The protocol follows Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines
(see Table 1 and Additional File 1 SPIRIT checklist).

Fig. 1 Study flow chart
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Participants

A total of 360 people will be recruited to participate in the
main study (120 per arm) and will be randomly allocated to
one of the three study conditions. All participants will be recruited from residential AOD treatment services located in
NSW (The Salvation Army, WHOS). Participants attending
these programs tend to have had longer term substance use
problems (e.g. 19-years [17];) and present with a complex
range of co-occurring mental health conditions [13, 14, 17,
18, 20, 21]. Alcohol tends to be the most commonly reported primary substance of dependence across both The
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Table 1 SPIRIT table
Study Period
Recruitment

Baseline

Randomisation

Intervention

Follow-up

Week

0

0

a

1–12

3-month

6-month

Contacted by

CCW

CCW

CCW

CCW

RA

RA

Continuing Care Project × 12 sessions

~Week 1–12

X

X

Continuing Care Project × 4 sessions

~Week 1–4

X

X

Treatment as Usual

–

X

X

ENROLMENT
Eligibility screen

X

Informed consent

X

Baseline assessment

X

Continuing Care Plan

X

Allocation

X

INTERVENTION

ASSESSMENTS
Demographic information

X

Timeline Follow Back

X

X

X

Substance Use Recovery Evaluator (SURE)

X

X

X

Drug Taking Confidence Questionnaire (DTCQ-8)

X

X

X

Lifetime Drug Use History (LDUH; Sections 11 and 12)

X

X

X

Desires for Alcohol Questionnaire (DAQ-6)
EUROHIS QOL 8-item index

X

X

X

Kessler-10 (K10)

X

X

X

Short-Form-12 (SF-12)

X

X

X

Brief Treatment Outcome Measure: Blood Borne Virus Risk items

X

X

X

Heaviness of Smoking Index (HIS)

X

X

X

UCLA Loneliness measure (3-items)
Health Literacy Questionnaire (HLQ)

X

X

X

Eating Disorder Screen for Primary Care (ESP)

X

X

X

Client Services Receipt Inventory (CSRI)

X

X

X

randomization occurs when the participant leaves the service – which could be planned or unplanned discharge. CCW Continuing Care Worker, RA Research
Assistant blind to treatment allocation
a

Salvation Army and WHOS. This is followed by methamphetamine and opiates [17, 20]. Poly-substance use is common amongst people attending these programs.

are [1] currently at risk of suicide, [2] have unstable
mental health symptoms.
Recruitment and screening

Inclusion / exclusion criteria

Participants will be required to be attending residential
services provided by The Salvation Army or WHOS.
Participants will be required to [1] have a substance use
disorder (i.e. not be attending the service for only a gambling problem), [2] have stayed in the residential facility
for at least 4-weeks, and [3] have access to a telephone
to complete the intervention when they leave the residential program. Exclusion criteria will be kept to a
minimum to promote the generalizability of the results.
Participants will only be excluded from the study if they

Continuing care workers (CCWs) will be employed at
each of the treatment sites to facilitate the continuing
care intervention. CCWs will give presentations at regular intervals to residents at the treatment site that they
are employed. These presentations will provide an overview of the Continuing Care Project and will reinforce
that participation in the study is voluntary. At the end of
these presentations, residents of the treatment facility
will indicate whether they are interested in participating
in the project using a pen and paper survey form. Only
interested residents will be then contacted to discuss
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Eligible consenting participants will be randomly allocated
to arms 1, 2 or 3 using central computerized randomization.
The allocation sequence will be generated using permuted
block randomisation (blocks of size 4) by an independent
statistician at the Clinical Research Design, IT and Statistical
Support (CReDITSS) unit at the Hunter Medical Research
Institute (HMRI). Participants will be stratified based on age
(under 25 and over 25) and organisation. This will provide
an opportunity to examine the impact of the intervention
on young people. At entry, the study participants will be allocated a study number.

Continuing care interventions: Participants allocated to
arms 2 and 3 of the study are offered continuing care telephone sessions in addition to the continuing care plan.
The continuing care telephone sessions follow the protocol developed by McKay et al. (2010). The aim is to deliver
the sessions weekly (i.e. 12-weeks for Arm 1 and 4-weeks
for Arm 2). However, it is recognised that there may be
times where sessions are missed, or it is not possible to
schedule an appropriate time. Where weekly sessions are
missed, participants will be given the opportunity to
schedule multiple weekly sessions. For both arms 1 and 2,
there is a 12-week period to complete all allocated sessions. The weekly sessions will take between 15 to 30 min
to complete. These sessions include a check on mental
health symptoms, and counselling around triggers, highrisk situations, coping strategies and recovery-related
activities. Participants are encouraged to identify and
plan for future high-risk situations and reflect on and
set substance-related goals. The procedures for the
continuing care telephone intervention also include
offering face-to-face appointments or more frequent
telephone contact with participants if they are at significant risk of relapse or adverse events [22, 23]. This is in
line with recommendations that continuing care interventions offer step-up treatment options for people struggling
[4, 6]. Details of any stepped care sessions will be recorded. As the current study is interested in examining
the optimal length of continuing care/number of telephone sessions required, the study design includes either a
4-session arm (1-month) or a 12-session arm (3-months).

Interventions

Follow-up

Treatment as usual and continuing care plan: Participants allocated to all three arms of the study will continue to complete treatment as usual whilst they are
attending the residential treatment program. This will
include the standard discharge procedures used at each
site (e.g. aftercare plan developed with case manager, encouraged to attend mutual support groups, referrals by
the person’s case manager to services in the community).
In addition to treatment as usual, all participants will develop a written continuing care plan with the CCW (approximately 1-h session). This plan was taken from the
McKay et al. (2010) protocol. It is a take-home resource
where participant treatment goals are identified, highrisk situations for relapse are planned for and prorecovery activities are detailed. This plan involves
reviewing the reasons that the participant wants to
change their alcohol and/or substance use, identifying
and discussing strategies to manage high risk situations,
reviewing rewarding activities that the person can engage in once they leave residential treatment, establishing recovering goals, and identifying support people for
the participant.

Research assistants based at The University of Wollongong will conduct 3- and 6-month post-discharge followup assessments over the telephone and will be blind to
participant allocation. At the beginning of each phone call,
participants will be reminded to not disclose their condition to the research assistant. If participants reveal their
condition, an alternative research assistant will complete
the assessment. Assessments will take approximately 30
min to complete. Contact (once per day between Monday
and Friday, as required) will be attempted by the research
assistant rostered that day (telephone call, SMS, email)
within 4-weeks of the eligibility date. Alternate contact details provided by the participant will be used if there is difficulty reaching the participant.

participation in more detail with the CCW and review
participant information. If the resident decides that they
would like to participate at this stage, written consent
for participation will be obtained.
The CCW will complete baseline data collection (see
Table 1) followed by a Continuing Care plan (see Fig. 1).
These will occur face to face with the participant prior to
exiting treatment (approximately 1 h session). This will
provide an opportunity for the worker to establish rapport
with the participants and develop a detailed understanding
of the person’s background. When the resident exits treatment, the CCW will make contact via telephone. During
this contact, randomisation procedures are completed and
contact between the CCW and the participant thereafter
is guided by the condition to which the person has been
allocated (i.e., 12 x telephone sessions, 4 x telephone sessions or no telephone sessions).
Randomisation

Loss to follow-up

Participants who cannot be contacted within 4-weeks of
the 3-month assessment eligibility date will be considered missing at that data collection time point. Research
assistants will attempt to contact participants again at
the 6-month time point. The exception to this will be if
the participant actively withdraws from the study,
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whereby the participant will be immediately removed
from the follow-up calling list.
Retention

The study will use retention enhancement techniques
developed from previous studies [13–15]. These include
flexibility in scheduled call times (after hours, weekends)
and using text messages to communicate study details
with participants or reminders before scheduled calls.
Reimbursement

Participants will be reimbursed with AUD$40.00
vouchers for baseline assessment, 3- and 6- month assessments. Vouchers will be posted to the current address provided by the participant at each time point.
Data collection

Data for the project will be collected and initially stored
in a Research Electronic Data Capture (REDCap) database, hosted locally on HMRI servers.
Trial monitoring
Intervention delivery

Drug and alcohol workers will be recruited from within
The Salvation Army and WHOS to work as CCWs and will
be based at treatment sites. Face-to-face training will be
completed by the research team (PK, BO, TD) with each of
the CCWs. Training will cover research procedures and
role-plays of assessment instrument administration, the initial face-to-face session, additional face-to-face sessions if
needed, and telephone treatment sessions. Training will be
supported by weekly supervision sessions (approximately 1
h a week; led by PK, BO).
Treatment fidelity

Prior to commencement of the study the CCWs will be
trained to competency in both the assessment and intervention protocols. This will include auditing mock sessions conducted by the clinicians. Once the study
commences, all assessment and intervention sessions will
be audiotaped. Independent psychologists will rate a random allocation of treatment sessions for fidelity and competence, and provide feedback to the CCWs throughout
the study to maintain fidelity. These tapes will also be
reviewed within supervision to support adherence.
Adverse events

All adverse events will be recorded by CCWs and research assistants between the time of recruitment and
the final follow-up assessment.
Participant withdrawal

Participants may withdraw at any point during the study
without any consequence and this is clearly outlined in
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the participant information sheet and consent process.
No further contact with the participant will be initiated
by the research team upon verbal or written withdrawal
from study.
Assessment procedures
Primary and secondary outcome measures

Primary outcome The primary outcome will be
percentage of days abstinent from alcohol and other
drugs (excluding tobacco) over the 28-day period immediately prior to the 6-month follow-up. This will be measured using the well-established Timeline Follow-Back
Method [24].
Secondary dependent variables At 3- and 6-months
assessment points, secondary analysis will examine selfreport recovery outcomes using the Substance Use Recovery Evaluator (SURE), psychological distress using
the Kessler-10, confidence using the Drug Taking Confidence Questionnaire (DTCQ-8), Quality of Life using
the EUROHIS Quality of Life 8-item index, physical
health using Short Form-12, and health literacy using
the Health Literacy Questionnaire. The Lifetime Drug
Use History questionnaire will be used to assess the
range of services that the person accessed following discharge from the residential program (e.g. mutual support
groups, general practitioner, other substance abuse treatment). See Table 1 for a list of the measures used in the
current study.
File audits of the participants’ electronic records (i.e. The
Salvation Army SAMIS system and the WHOS Ted system) will be conducted to identify the care the person received whilst in the facility (i.e. length of stay, attendance at
group programs, involvement in mutual support groups, referrals, and engagement in any other forms of care).
Data analysis
Power analysis

A sample of 90 per group will give the study 80% power
to detect a 0.3 standardised difference between intervention groups in the change from baseline percentage days
abstinent (PDA) at a 5% significance threshold. This calculation assumes a correlation between baseline and
follow-up of 0.7. A meta-analysis of continuing care
treatment effects for participants with substance dependence disorders identified a pooled treatment standard
deviation (SD) of ~ 0.3SD (reference?). A SD of 30% for
PDA has been reported elsewhere [24], so a 0.3 SD difference corresponds to a clinically meaningful difference
of 10% between the treatment groups [25]. Based on a
follow-up of 75% of participants at 6-months, we will recruit 360 participants to the study to ensure sufficient
power.
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Analysis plan

The analysis will follow the intention to treat principle.
The difference between treatment groups in the primary
outcome will be assessed using a linear regression model.
The outcome in the model will be percentage days abstinent at 6-month follow-up, and the model will include fixed
effects for the baseline value of the outcome, treatment
group, and the stratification variables. Significance tests of
the differences between treatment groups at 6-months will
be based off estimated marginal means using a Waldbased t-test. Modelling assumptions will be assessed using
graphical techniques, and appropriate changes made if the
assumptions are violated (bootstrapping standard errors
for example). Differences in secondary outcomes will be
assessed using similar models for continuous outcomes;
and logistic regression models for dichotomous outcomes.
Generalised linear mixed models will be used for comparison of outcomes that are measured at multiple postbaseline time-points using an unstructured residual
correlation matrix and fixed effects for time, treatment
and the interaction between time and treatment. Missing
data will be imputed multiple times using the chained regression equations method, with treatment effect estimated pooled across imputations using Rubin’s method.
Economic evaluation

Taking a health sector perspective, a within-trial costeffectiveness analysis will be based on the relative
change, between baseline and 6-month post intervention, in the primary outcome variable: percentage days
abstinent. This will be done comparing the three trial
arms: usual continuing care versus 4 sessions, usual continuing care versus 12 sessions, and 4 sessions versus 12
sessions. Cost collection will include three elements: the
cost of delivering the sessions (e.g. staff time, training
and supervision), the flow-on cost impacts to other services (e.g. allied health and hospitalisations) and client
out-of-pocket costs (e.g. co-payments) using a modified
Client Services Receipt Inventory (CSRI; 26) (CSRI). In
addition, the economic evaluation will be repeated in a
cost-utility analysis where the measure of outcome is
health-utility which is an economic measure of healthrelated quality of life derived from the SF-12. A full uncertainty analysis will be undertaken including an assessment of the value of undertaking further research.

Discussion
The purpose of the Continuing Care Project is to trial a
continuing care telephone intervention for people leaving
residential AOD treatment in Australia. Strengths of the
study include participant recruitment from multiple service
providers (i.e., The Salvation Army, WHOS) across four
treatment sites. Treatment sites from urban and regional
areas of New South Wales have been included in an effort
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to increase the heterogeneity of the sample and enhance the
generalizability of the findings. Exclusion criteria for the
study has also been kept to a minimum to promote
generalizability. For example, the study includes both males
and females, participants with with co-occurring mental illness and has no exclusionary criteria based on primary substance. The proposed trial will extend on the existing
research on the continuing care intervention [10–12] by
recruiting a sample from residential treatment services rather than from outpatient services. Providing opportunity to
examine whether the clinical and cost effectiveness of the
intervention found in outpatient samples is applicable to
those receiving inpatient treatment from residential settings.
Challenges of completing intervention research at residential substance use services has been documented [15]. These
challenges include the high rates of unplanned attrition and
difficulty retaining participants for follow-up assessment.
Tending too these challenges, continuing care plans will be
completed within seven days of the baseline assessment.
Since participants will only be eligible for randomization
after the continuing care plan is complete, this strategy will
help retain participants to the point of treatment allocation.
Attempts to improve follow-up rates in the current study
will include using telephone follow-up, obtaining contact
details of significant others to help with locating participants
and financially compensating participants for the time required to complete the assessments (AUD$40.00).

Conclusion
The proposed study addresses calls in the broader academic
literature to conduct well-controlled studies of continuing
care interventions for residential substance use populations
[4–6]. The study will provide important information on the
clinical effectiveness and cost effectiveness of including
continuing care telephone interventions as part of AOD
services. It is anticipated that the current study will demonstrate that a continuing care intervention is a relatively lowcost clinical intervention that can help to support people
following residential care. The study will also provide evidence on the number of telephone sessions required to improve abstinence and other outcomes as part of the
continuing care intervention. Results from the current
study may also help to inform the implementation of continuing care interventions for other outcomes that can
affect people accessing AOD treatment (i.e. mental illness,
poverty, homelessness, criminal involvement).
Trial status
The trial is registered with the Australian New Zealand
Clinical Trials Registry - ACTRN12618001231235. It was
first registered on 23rd July 2018 and the most recent update to the trial was 25th June 2019. To date, 216 participants have been randomized. Recruitment of participants is
expected to be completed by December 2019.
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